Atossa Genetics Inc.
Company Information

2300 Eastlake Ave E Ste 200
Seattle, WA, 98102 United States
(800) 351-3902

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


Atossa Genetics Inc. Company Profile

A development-stage company, Atossa Genetics owns and markets the MASCT (Mammary Aspirate Specimen Cytology Test) System, which was created by Atossa founder Steven Quay and tests for precursors to breast cancer. The MASCT System goes beyond mammograms in that it can detect genetic pre-cancerous conditions in the breast up to eight years before a mammography. Patented and approved by the FDA, the device is a handheld pump used to collect fluid from breast milk ducts in about 10 minutes. Atossa also offers related screening tests. The company filed an initial public offering (IPO) in 2010, but later withdrew the offering; it filed again in 2012.